Stay updated on Periop Chemo & Pembrolizumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Periop Chemo & Pembrolizumab in Gastric Cancer Clinical Trial page.

Latest updates to the Periop Chemo & Pembrolizumab in Gastric Cancer Clinical Trial page
- Check3 days agoChange DetectedA new Results section has been added, detailing primary and secondary outcomes (pCR, OS, DFS, ORR) and time frames, along with the dates of results submission.SummaryDifference0.1%

- Check10 days agoChange DetectedRevision: v3.5.0 added and v3.4.3 removed, updating the page's revision metadata to v3.5.0.SummaryDifference0.1%

- Check17 days agoChange DetectedThe page was redesigned with a new layout and navigation; substantive study data such as eligibility, outcomes, and enrollment appear unchanged.SummaryDifference0.1%

- Check24 days agoChange DetectedRevision: v3.4.3 updated from v3.4.2.SummaryDifference0.1%

- Check46 days agoChange DetectedAn entry for Gastric cancer and a link to the Genetic and Rare Diseases Information Center were added under Resources. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page footer now displays Revision: v3.4.2. The notice about lapses in government funding and the related operating status update has been removed.SummaryDifference0.4%

Stay in the know with updates to Periop Chemo & Pembrolizumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Periop Chemo & Pembrolizumab in Gastric Cancer Clinical Trial page.